Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology
recent articles
Less than five months after its launch, French startup Bioptimus has announced the release of H-optimus-0, the world’s largest open-source AI foundation model for pathology. With 1.1 billion parameters, H-optimus-0 is trained on a...
From the NVIDIA blog. Paige Cofounder sits down with AI Podcast's Noah Kravits to discuss potential changes AI could bring to healthcare. Improved cancer diagnostics — and improved patient outcomes — could be among the changes...
From Aiosyn via Pathology News: What is chronic kidney disease (CKD)? Chronic kidney disease (CKD) is a progressive condition where the kidneys gradually lose function [1]. It is characterized by a high morbidity and mortality rate, and it is...
Researchers from Case Western Reserve University, Cleveland Clinic and University Hospitals are using artificial intelligence to better treat rectal cancer. Doing so can help patients avoid unnecessary and invasive surgeries. It's the first...
Aim of the [Merck-Afrigen Biologics] collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Merck, a leading science and technology company, announced that its Life Science...
Published in bioRxiv, the study leverages Pangea Biomed’s ENLIGHT platform to develop a novel approach to precision cancer care that combines AI techniques and digital pathology, bypassing the need for expensive and time-consuming DNA and RNA...
